Report cover image

Antibody-Drug Conjugate Drug Landscape

Publisher GlobalData
Published Jan 29, 2026
Length 53 Pages
SKU # GBDT20865643

Description

Antibody-Drug Conjugate Drug Landscape

Summary

This report investigates the impacts and development of Antibody-Drug Conjugate therapies within the pharmaceutical industry from the standpoint of drug development. It provides a high-level analysis of key trends and movements within the industry via regulatory, clinical, and market-based analysis, allowing you to discern the large-scale changes within the market and how best to pivot to prioritize future changes in the market.

Scope
  • This 53-page report gives important, expert insight you won’t find in any other source. 28 figures throughout the report illustrate major points and trends within the Antibody- Drug Conjugate market delving deep into forecasted sales and company pipelines. This report is required reading for -
  • Investors that want to understand past trends impacting the Antibody- Drug Conjugate landscape as well as identifying companies to invest in
  • Companies that are interested in entering the Antibody- Drug Conjugate landscape and where best to focus on
  • Large pharma companies with investment groups or BD teams looking to see which companies lead the Antibody- Drug Conjugate landscape in the past and how they led
  • Small and medium pharma who want to focus their Antibody- Drug Conjugate drug portfolio on future trends and are looking for partnership opportunities
Reasons to Buy
  • Insights on the different types of Antibody- Drug Conjugate with current and novel forms
  • Insights on past trends and changes that have informed the Antibody- Drug Conjugate market
  • Insights on the current leading Antibody- Drug Conjugate drugs based on their Sales and Forecasts and other parameters
  • Therapeutic and Indication insights into the Antibody- Drug Conjugate market
  • Insights into the future opportunities for Antibody- Drug Conjugate and the companies leading in the market.

Table of Contents

53 Pages
1 Antibody-Drug Conjugate Introduction
1.1 Key milestones timeline
1.2 Total market sales
1.3 Point-in-time counts
2 Antibody-Drug Conjugate: Previous Years in Review
2.1 ADCs by development stage
2.2 Approvals timeline
2.3 Historical sales
2.4 Deals trends
2.5 Patents trends
2.6 Review designation trends
3 Antibody-Drug Conjugate: Current Landscape
3.1 ADCs by development stage
3.2 Top indications
3.3 Top companies
4 Antibody-Drug Conjugate: Future Outlook
4.1 Forecast sales
4.2 Top companies
4.3 Upcoming launches
5 Key Findings
6 Appendix
6.1 Abbreviations
6.2 Methodology
6.3 About the Authors
6.4 About GlobalData
6.5 Contact Us

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us